Trial site
Combined Research Orlando Phase I-IV
- 10running trials
- 10closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Depression5 trials
- Gout3 trials
- Mild cognitive impairment2 trials
- Obesity2 trials
- IgA nephropathy1 trial
- Narcolepsy1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 315 trials
- Phase 2/33 trials
- Phase 22 trials
- Status
- Completed8 trials
- Active, not recruiting5 trials
- Recruiting4 trials
- Terminated2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Amgen2 trials
- Atom Therapeutics Co., Ltd2 trials
- Biohaven Pharmaceuticals, Inc.2 trials
- Cybin IRL Limited2 trials
- Novo Nordisk A/S2 trials
- and 9 more
Running trials
Recruiting
Recruiting
Recruiting
Enrolling by invitation
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
Active, not recruiting
An Open-Label Study of Azetukalner in Major Depressive Disorder
Active, not recruiting
Active, not recruiting
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Active, not recruiting
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Recruiting
Active, not recruiting
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- Depression1 recruiting
- Gout1 recruiting
- Narcolepsy1 recruiting
- Obesity1 recruiting
Closed trials
Completed
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
Terminated
Completed
Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout
Completed
Completed
A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia
Completed
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Terminated
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
Completed
Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
Site data: ClinicalTrials.govUpdated 18 Nov 2026